neurokinin a (4-10), nle(10)- has been researched along with 4-diphenylacetoxy-n-methylpiperidine methiodide in 3 studies
| Studies (neurokinin a (4-10), nle(10)-) | Trials (neurokinin a (4-10), nle(10)-) | Recent Studies (post-2010) (neurokinin a (4-10), nle(10)-) | Studies (4-diphenylacetoxy-n-methylpiperidine methiodide) | Trials (4-diphenylacetoxy-n-methylpiperidine methiodide) | Recent Studies (post-2010) (4-diphenylacetoxy-n-methylpiperidine methiodide) |
|---|---|---|---|---|---|
| 21 | 0 | 3 | 27 | 0 | 10 |
| Protein | Taxonomy | neurokinin a (4-10), nle(10)- (IC50) | 4-diphenylacetoxy-n-methylpiperidine methiodide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.055 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0005 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0045 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
3 other study(ies) available for neurokinin a (4-10), nle(10)- and 4-diphenylacetoxy-n-methylpiperidine methiodide
| Article | Year |
|---|---|
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |